Evaluation of selected risk factors of cardiovascular diseases among patients after kidney transplantation, with particular focus on the role of 24-hour automatic blood pressure measurement in the diagnosis of hypertension: An introductory report

Annals of Transplantation

Volumn 19, Issue 1, 2014, Pages 188-198

  Czyzewski, Łukasz ^a   Wyzgał, Janusz ^a   Kołek, Anna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

ABPM; Adherence; Arterial hypertension; Kidney transplant

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; DELAYED GRAFT FUNCTION; DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; FEMALE; GLOMERULONEPHRITIS; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT ATTITUDE; QUESTIONNAIRE; WHITE COAT HYPERTENSION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CREATININE; FEMALE; HUMANS; HYPERTENSION, RENAL; KIDNEY TRANSPLANTATION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PRIMARY GRAFT DYSFUNCTION; QUESTIONNAIRES; RISK FACTORS; WHITE COAT HYPERTENSION;

EID: 84900022351     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.890189     Document Type: Article

References (71)

1. Port FK, Wolfe RA, Mauger EA et al: Comparison of survival probabilities for dialysis patients vs. cadaveric renal transtransplant recipients. JAMA, 1993; 270: 1339-43
2. Wolfe RA, Ashby B, Milford EL et al: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med, 1999; 341: 1725-30
3. Wu O, Levy A, Briggs A et al: Acute rejection and chronic nephropathy: a systemic review of the literature. Transplantation, 2009; 87: 1330-39
4. Hariharan S, Johnson CP, Bresnahan BA et al: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med, 2000; 342: 605-12
5. rd ed.: Informa Healthcare, 1998
6. Pascual M, Theruvath T, Kawai T et al: Strategies to improve long-term outcomes after renal transplantation. N Engl J Med, 2002; 346: 580-90
7. Gourishankar S, Melk A, Halloran P: Nonimmune mechanisms of Injury in renal transplantation. Transplant Rev, 2002; 16: 73-86
8. Collins AJ, Foley RN, Herzog C et al: United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis, 2009; 53: 1-374
9. U.S. Renal Data System USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2013. http://www.usrds.org. Accessed October 27, 2013
10. Kahwaji J, Bunnapradist S, Hsu JW et al: Cause of death with graft function among renal transplant recipients in an integrated healthcare system. Transplantation, 2011; 91: 225-30
11. Ojo AO, Hanson JA, Wolfe RA et al: Long-term survival in renal transplant recipients with graft function. Kidney Int, 2000; 57: 307-13
12. Matas AJ, Humar A, Gillingham KJ et al: Five preventable causes of kidney graft loss in the 1990s: a single-center analysis. Kidney Int, 2002; 62: 704-14
13. Opelz G, Wujciak T, Ritz E: Association of chronic kidney graft failure with recipient blood pressure. Kidney Int, 1998; 53: 217-22
14. Opelz G, Dohler B: Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant, 2005; 5: 2725-31
15. Dunn BL, Teusink AC, Taber DJ et al: Management of hypertension in renal transplant patients: a comprehensive review of nonpharmacologic and pharmacologic treatment strategies. Ann Pharmacother, 2010; 44: 1259-70
16. Lewington S, Clarke R, Qizilbash N et al: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, 2002; 360: 1903-13
17. Kalaitzidis RG, Bakris GL: Prehypertension: is it relevant for nephrologists? Kidney Int, 2010; 77: 194-200
18. Paoletti E, Gherzi M, Amidone M et al: Association of arterial hypertension with renal target organ damage in kidney transplant recipients: the predictive role of ambulatory blood pressure monitoring. Transplantation, 2009: 87: 1864-69
19. Kasiske BL, Anjum S, Shah R et al: Hypertension after kidney transplantation. Am J Kidney Dis, 2004; 43: 1071-81
20. Mangray M, Vella J: Hypertension after kidney transplant. Am J Kidney Dis, 2011; 57: 331-41
21. Ponticelli C, Cucchiari D, Graziani G: Hypertension in kidney transplant recipients. Transpl Int, 2011; 24: 523-33
22. Weir MR, Salzberg DJ: Management of hypertension in the transplant patient. J Am Soc Hypertens, 2011; 5: 425-32
23. Kasiske BL: Cardiovascular disease after renal transplantation. Semin Nephrol, 2000; 20: 176-87
24. Kasiske BL, Chakkera HA, Roel J: Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol, 2000; 11: 1735-43
25. Ojo AO: Cardiovascular complications after renal transplantation and their prevention. Transplantation, 2006; 82: 603-11
26. Campistol JM, Romero R, Paul J, Gutiérrez-Dalmau A: Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade. Nephrol Dial Transplant, 2004; 19: iii62-66
27. Wadei HM, Textor SC: Hypertension in the kidney transplant recipient. Transplant Rev, 2010; 24: 105-20
28. Chatzikyrkou C, Menne J, Gwinner W et al: Pathogenesis and management of hypertension after kidney transplantation. J Hypertens, 2011; 29: 2283-94
29. Mange KC, Cizman B, Joffe M, Feldman HI: Arterial hypertension and renal allograft survival. JAMA, 2000; 283: 633-38
30. Sarnak MJ, Levey AS: Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis, 2000; 35: 117-31
31. Marino PL. The ICU Book, Urban & Partner, 2001; 145
32. Dolan E, Stanton A, Thijs L et al: Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension, 2005; 46: 156-61
33. Beltran S, Crespo J, Kanter J et al: Ambulatory blood pressure monitoring in renal transplant patients: should it be routinely performed? Transplant Proc, 2010; 42: 2868-70
34. Boggia J, Li Y, Thijs L et al: Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet, 2007; 370: 1219-29
35. Haydar AA, Covic A, Jayawardene S et al: Insights from ambulatory blood pressure monitoring: diagnosis of hypertension and diurnal blood pressure in renal transplant recipients. Transplantation, 2004; 77: 849-53
36. Peixoto AJ, White WB: Ambulatory blood pressure monitoring in chronic renal disease: technical aspects and clinical relevance. Curr Opin Nephrol Hypertens, 2002; 11: 507-16
37. Bangash F, Agarwal R: Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol, 2009; 4: 656-64
38. Kayrak M, Gul EE, Kaya C et al: Masked hypertension in renal transplant recipients. Blood Press, 2013; 31
39. Stenehjem AE, Gudmundsdottir H, Os I: Office blood pressure measurements overestimate blood pressure control in renal transplant patients. Blood Press Monit, 2006; 11: 125-33
40. Prasad GV, Nash MM, Zaltzman JS: A prospective study of the physician effect on blood pressure in renal-transplant recipients. Nephrol Dial Transplant, 2003; 18: 996-1000
41. Fernandez FG, Franco EA, Gomez HE et al: Ambulatory blood pressure monitoring in kidney transplant patients: RETENAL study. Transplant Proc, 2012; 44: 2601-2
42. Mancia G, Fagard R, Narkiewicz K et al: 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens, 2013; 31: 1925-38
43. Eckardt KU, Kasiske BL: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Am J Transplant, 2009; 9: 1-155
44. O'Brien E, Asmar R, Beilin L et al: Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens, 2005; 23: 697-701
45. O'Brien E, Parati G, Stergiou G et al: European society of hypertension position paper on ambulatory blood pressure monitoring. J Hypertens, 2013, 31: 1731-68
46. O'Brien E, Waeber B, Parati G et al: Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ, 2001; 322: 531-36
47. Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care, 1986; 24(1): 67-74
48. Upadhyay A, Earley A, Haynes SM, Uhlig K: Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier. Ann Intern Med, 2011; 154: 541-48
49. Zanchetti A, Grassi G, Mancia G: When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens, 2009; 27: 923-34
50. Appel LJ, Wright JT Jr, Greene T et al: Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med, 2010; 363: 918-29
51. Mancia G, Laurent S, Agabiti-Rosei E et al: Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens, 2009; 27: 2121-58
52. Bloch MJ, Basile J: African American Patients With Hypertensive Chronic Kidney Disease Receive No Benefit on Kidney Disease Progression from the Currently Recommended Blood Pressure Goal of <130/80 mm Hg Unless There Is Significant Proteinuria at Baseline: Long-Term Follow-Up of the AASK Study. J Clin Hypertens, 2011; 13: 214-16
53. Jacobi J, Rockstroh J, John S et al: Prospective analysis of the value of 24-hour ambulatory blood pressure on renal function after kidney transplantation. Transplantation, 2000; 70: 819-27
54. Matteucci MC, Giordano U, Calzolari A et al: Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients. Kidney Int, 1999; 56: 1566-70
55. Sega R, Facchetti R, Bombelli M et al: Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni. Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation, 2005; 111: 1777-83
56. Dew MA, DiMartini AF, De Vito Dabbs A et al: Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation, 2007; 83: 858-73
57. Balkrishnan R: The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care, 2005; 43: 517-20
58. Didlake RH, Dreyfus K, Kerman RH et al: Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc, 1998; 20: 63-69
59. Brahm MM, Manfro RC, Mello D et al: Evaluation of adherence to immunosuppressive drugs in kidney transplantation by control of medication dispensing. Transplant Proc, 2012; 44: 2391-93
60. Dickinson HO, Mason JM, Nicolson DJ et al: Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens, 2006; 24: 215-33
61. Kurnatowska I, Królikowski J, Jesionowska K et al: Prevalence of arterial hypertension and the number and classes of antihypertensive drugs prescribed for patients late after kidney transplantation. Ann Transplant, 2012; 17: 50-57
62. Curtis JJ: Hypertensinogenic mechanism of the calcineurin inhibitors. Curr Hypertens Rep, 2002; 4: 377-80
63. Naesens M, Kuypers DR, Sarwal M: Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol, 2009; 4: 481-508
64. Katznelson S, Wilkinson AH, Kobashigawa JA et al: The effect of pravastatin on acute rejection after kidney transplantation-a pilot study. Transplantation, 1996; 61: 1469-74
65. Roodnat JI, Mulder PG, Zietse R et al: Cholesterol as an independent predictor of outcome after renal transplantation. Transplantation, 2000; 69: 1704-10
66. Kamar N, Rostaing L: Negative impact of one-year anemia on long-term patient and graft survival in kidney transplant patients receiving calcineurin inhibitors and mycophenolate mofetil. Transplantation, 2008; 85: 1120-24
67. Staessen JA, O'Brien ET, Amery AK et al: Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database. J Hypertens Suppl, 1994; 12: 1-12
68. Wen KC, Gourishankar S: Evaluating the utility of ambulatory blood pressure monitoring in kidney transplant recipients. Clin Transplant, 2012; 26: 465-70
69. Dolan E, Stanton A, Atkins N et al: Determinants of white-coat hypertension. Blood Press Monit, 2004; 9: 307-9
70. Ibernon M, Moreso F, Sarrias X et al: Reverse dipper pattern of blood pressure at 3 months is associated with inflammation and outcome after renal transplantation. Nephrol Dial Transplant, 2012; 27: 2089-95
71. Fagard RH, Cornelissen VA: Incidence of cardiovascular events in whitecoat, masked and sustained Hypertension, vs. true normotension: a metaanalysis. J Hypertens, 2007; 25: 2193-98